Literature DB >> 12452325

A single-nucleotide polymorphism in C-type natriuretic peptide gene may be associated with hypertension.

Koh Ono1, Toshifumi Mannami, Shunroku Baba, Hitonobu Tomoike, Sin-ichi Suga, Naoharu Iwai.   

Abstract

We conducted an association study between genetic variants of C-type natriuretic peptide gene (CNP) and hypertension in a Japanese population. We found four genetic variants, two in the promoter region, one missense mutation, and one in the 3'-untranslated region (3'-UTR), and genotyped all four variants in 2,006 subjects recruited from the Suita study. One of the variants, G2628A in 3'-UTR, was found to be associated with blood pressure. Multiple logistic analyses indicated that the genotype of the G2628A polymorphism (GG=1, GA+AA=2) (p=0.0034), sex (p=0.0288), alcohol consumption (p=0.0002), age (p<0.0001), and body mass index (p<0.0001) were predictors of hypertension. The odds ratio of the GA+AA genotype over the GG genotype for hypertension was 1.40 (p=0.0034, 95% confidence interval (CI) 1.12-1.75). Multiple logistic analyses in a younger subpopulation aged below 65 years indicated that the odds ratio of the GA+AA genotype over the GG genotype for hypertension was 1.58 (p=0.0024, 95%CI 1.18-2.12). Thus, the CNP G2628A polymorphism made an even greater contribution to hypertension in the younger subpopulation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12452325     DOI: 10.1291/hypres.25.727

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  10 in total

Review 1.  A systematic analysis of disease-associated variants in the 3' regulatory regions of human protein-coding genes II: the importance of mRNA secondary structure in assessing the functionality of 3' UTR variants.

Authors:  Jian-Min Chen; Claude Férec; David N Cooper
Journal:  Hum Genet       Date:  2006-06-29       Impact factor: 4.132

2.  The mRNA-destabilizing protein Tristetraprolin targets "meiosis arrester" Nppc mRNA in mammalian preovulatory follicles.

Authors:  Guangyin Xi; Lei An; Wenjing Wang; Jing Hao; Qianying Yang; Lizhu Ma; Jinlun Lu; Yue Wang; Wenjuan Wang; Wei Zhao; Juan Liu; Mingyao Yang; Xiaodong Wang; Zhenni Zhang; Chao Zhang; Meiqiang Chu; Yuan Yue; Fusheng Yao; Meijia Zhang; Jianhui Tian
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-01       Impact factor: 11.205

Review 3.  Pharmacogenomics of the Natriuretic Peptide System in Heart Failure.

Authors:  Ahmed Abuzaanona; David Lanfear
Journal:  Curr Heart Fail Rep       Date:  2017-12

Review 4.  Natriuretic peptide receptor B signaling in the cardiovascular system: protection from cardiac hypertrophy.

Authors:  Ines Pagel-Langenickel; Jens Buttgereit; Michael Bader; Thomas H Langenickel
Journal:  J Mol Med (Berl)       Date:  2007-04-12       Impact factor: 4.599

Review 5.  C-type natriuretic peptide (CNP): cardiovascular roles and potential as a therapeutic target.

Authors:  Natalie G Lumsden; Rayomand S Khambata; Adrian J Hobbs
Journal:  Curr Pharm Des       Date:  2010       Impact factor: 3.116

6.  Increased circulating bioactive C-type natriuretic peptide is associated with reduced heart rate variability in patients with chronic kidney disease.

Authors:  Lulu Wang; Wenjin Liu; Yanting Yu; Lei Jiang; Junwei Yang
Journal:  BMC Nephrol       Date:  2018-03-05       Impact factor: 2.388

Review 7.  C-type Natriuretic Peptide: A Multifaceted Paracrine Regulator in the Heart and Vasculature.

Authors:  Amie J Moyes; Adrian J Hobbs
Journal:  Int J Mol Sci       Date:  2019-05-08       Impact factor: 5.923

8.  Endothelial C-type natriuretic peptide maintains vascular homeostasis.

Authors:  Amie J Moyes; Rayomand S Khambata; Inmaculada Villar; Kristen J Bubb; Reshma S Baliga; Natalie G Lumsden; Fang Xiao; Paul J Gane; Anne-Sophie Rebstock; Roberta J Worthington; Michela I Simone; Filipa Mota; Fernando Rivilla; Susana Vallejo; Concepción Peiró; Carlos F Sánchez Ferrer; Snezana Djordjevic; Mark J Caulfield; Raymond J MacAllister; David L Selwood; Amrita Ahluwalia; Adrian J Hobbs
Journal:  J Clin Invest       Date:  2014-08-08       Impact factor: 14.808

Review 9.  Natriuretic peptides in cardiovascular diseases.

Authors:  Mariusz Piechota; Maciej Banach; Anna Jacoń; Jacek Rysz
Journal:  Cell Mol Biol Lett       Date:  2008-04-10       Impact factor: 5.787

10.  Do N-Terminal Pro-C-Type Natriuretic Peptide Levels Relate to Severity of Preeclampsia?

Authors:  Dogan Vatansever; Pınar Vatansever; Burak Giray; A Aktug Ertekin; Serpil Bilsel
Journal:  Int J Hypertens       Date:  2020-05-02       Impact factor: 2.420

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.